MBP and multiple sclerosis: There are examples of people who produce abzymes with potentially clinically significant effects, for example, DNA (35), immunoglobulin (36), vasoactive intestinal peptide (VIP) (37), myelin basic protein (MBP) in persons with multiple sclerosis (38), and factors in the coagulation cascade (39, –, 41).